Bladder Cancer and Smoking

Transcript for: 
Bladder Cancer and Smoking

MS. DIANE REHM

10:06:55
Thanks for joining us. I'm Diane Rehm. A new study has found that smoking may be responsible for half of all bladder cancer cases. And for the first time, the risk to women smokers of developing bladder cancer is equal to that of men. Here in the studio is, one of the authors of the study, Dr. Neal Freedman from the National Cancer Institute, Lawrence Rzepka of the Bladder Cancer Advocacy Network.

MS. DIANE REHM

10:07:35
On the line with us from New York is Dr. Douglas Scherr of New York Presbyterian Hospital. Throughout the hour, we'll take your calls, your comments and questions, 800-433-8850. Send us your email to drshow@wamu.org. Join us on Facebook or Twitter. Good morning to all of you.

MR. LAWRENCE RZEPKA

10:08:10
Good morning.

DR. NEAL FREEDMAN

10:08:10
Good morning.

DR. DOUGLAS SCHERR

10:08:11
Good morning.

REHM

10:08:12
And, Dr. Freedman, if I could start with you, tell us about the study, how it was conducted and why you did it to begin with.

FREEDMAN

10:08:23
Sure. In 2009, our colleagues at the National Cancer Institute observed evidence for the strengthening association between cigarette smoking and bladder cancer. It's been known that bladder cancer is caused by cigarette smoking, among other factors, for a long time. But they observed in their study that evidence for strengthening of the association. And so we wanted to look in another study to see if we could replicate these findings.

FREEDMAN

10:08:51
So we looked in the very large NIH-AARP cohort, which was initiated by Arthur Schatzkin in 1995 and '96. And this was a study of nearly 500,000 members of AARP. In this study, current smokers were four times more likely to get bladder cancer than never smokers. And as part of our paper, we also looked to see in previous cohorts, previous studies that were performed in previous times.

FREEDMAN

10:09:20
So these were studies that were initiated between the '60s and '80s.

REHM

10:09:23
Hmm. So how many people were looked at here?

FREEDMAN

10:09:29
In our study, about 500,000.

REHM

10:09:31
And most of these people then -- you said AARP -- so above the age of 50 to...

FREEDMAN

10:09:39
That's right. To 71.

REHM

10:09:41
...to 71. What were the major findings, Dr. Freedman?

FREEDMAN

10:09:47
The major findings, there were two of them. The first was that the risk for current smokers versus never smokers, that the current smokers were four times more likely to get bladder cancer than never smokers. And in previous studies, which were initiated in the United States in earlier time periods, current smokers were only three times more likely to get bladder cancer.

FREEDMAN

10:10:06
So this provides evidence, similar to the 2009 study, that the strength of the association between cigarette smoking and bladder cancers increased.

REHM

10:10:15
Does your study actually prove a link between smoking and bladder cancer?

FREEDMAN

10:10:24
Our study doesn't prove it by itself. But there's many studies performed in different geographic areas and in combination with laboratory studies. And, together, the body of evidence strongly supports that cigarette smoking is a cause of bladder cancer.

REHM

10:10:39
It's so interesting, Dr. Freedman, because, as you well know, smoking in the United States has decreased in the last 30 years. So why hasn't the incidence of bladder cancer decreased?

FREEDMAN

10:10:57
That's a great question. We don't really know. There's a couple of possibilities. One of them is, in addition to smoking causing bladder cancer, there's other risk factors for bladder cancer, and there may be an additional risk factor that we don't know of that's contributing towards the stability of the bladder cancer incidence rates.

FREEDMAN

10:11:16
The other possibility is, because we're observing the evidence for strengthening of association between cigarette smoking and bladder cancer, it could be that, even though fewer people are smoking, the people that are smoking are at higher risk of bladder cancer, and that's contributing to the stability of the incidence rates over time.

REHM

10:11:34
Dr. Neal Freedman, he is one of the authors of a new report from the U.S. National Cancer Institute. Turning to you, Larry Rzepka, what do you make of this growing incidence of bladder cancer, especially among women smokers?

RZEPKA

10:11:58
Well, Diane, it's interesting. We find the study extremely important. For the last six years, BCAN, the Bladder Cancer Advocacy Network, has been looking at all the other studies that have come out linking smoking to bladder cancer. So, once again, a monumental study has been released that strengthens that argument. In regards to more women being diagnosed, are we surprised?

RZEPKA

10:12:22
Well, in our organization, we have a lot of anecdotal evidence that that's been happening. We get calls and emails all the time from women saying they have been missed diagnosed, not misdiagnosed, and there's a difference. The diagnosis has been missed, mainly because one of the main symptoms of bladder cancer is blood in your urine. So, for men, of course, when that happens, they might go to the doctor.

RZEPKA

10:12:52
For a woman, that is sometimes not unusual because of the menstrual cycle or a variety of other reasons. So when they go to their family physician or internist or GYN, they might say it's a urinary tract infection, and they treat it that way. So we find out, at least in some of the calls and emails we're getting, that women are saying, I went three times. They treated me three times for urinary tract infection. Then, finally, they did a test.

RZEPKA

10:13:24
So I think this study that comes out that says women are smoking more, or at least as much as men -- and that is now documented. I think that whatever the cigarette companies may have done in regards to thinking they're making a healthier cigarette might not be the case. We don't know. The jury is out, and I'm not a scientist. But there seems to be a link that the incidents of bladder cancer have remained stable over these past 30 years.

REHM

10:13:55
Lawrence Rzepka, he is executive director of the Bladder Cancer Advocacy Network. And turning to you, Dr. Douglas Scherr, tell us about this notion of bladder cancer in women somehow being missed. Do you see -- obviously, you are seeing patients who have bladder cancer. But do you agree that, too often, it's being missed?

SCHERR

10:14:30
Well, I think Lawrence had touched on a very important issue. In the most common presenting sign of bladder cancer being hematuria, or blood in the urine, is a much more "acceptable presence" in women than it is in men. And I think, you know, there needs to be an education not only with the population at hand, but also with the medical community as well, that hematuria, irrespective of gender, is something that needs to be evaluated and should be referred to the appropriate physicians for evaluation.

SCHERR

10:15:03
But I think the gender differences in bladder cancer have been, you know, evaluated for some time. And if we look at bladder cancer in general -- and this is, in part, maybe due to the later presentation. But I think, stage for stage and grade for grade, women tend to have a worse prognosis with bladder cancer than men.

REHM

10:15:23
Why is that?

SCHERR

10:15:25
Well, I think there are several factors. I think one is what we had touched upon initially, that women tend to present later on and perhaps because of the later presentation or later referral. But even if we look at women who have higher stage disease -- for example, a stage IV disease is a disease that involves the bladder and adjacent organs, and women tend to do much worse for that stage disease than men.

SCHERR

10:15:51
And I think, in part, that may be that the anatomy of the women or the female pelvis is such that there's a much thinner bladder wall. And bladder cancer can tend to spread outside the bladder at a more rapid pace in women than it can in men. I think there are likely to be some socioeconomic factors.

SCHERR

10:16:11
And I think what's probably most important, there's probably a -- known to be a hormonal regulation of bladder cancer that's really only at its infancy in our ability to understand the hormonal manipulation of bladder cancer.

REHM

10:16:25
I think that you've just pointed to one of my questions. The bladder cancer has always been referred to as an old man's disease. But what you're saying is that it has now become a female disorder. Does it normally strike older women? Or is it hitting younger women as well, Dr. Scherr?

SCHERR

10:16:57
Well, clearly, it is a disease of an aging population. And I think the longer exposure, for example, to tobacco smoke, is a much higher risk factor for developing bladder cancer. But we do see it across all generations, both young and older patients, both men and women. If we look at pre-menopausal versus post-menopausal women, there's clearly a higher incidence of bladder cancer in post-menopausal women.

SCHERR

10:17:23
And I think, as I mentioned earlier, the -- we're only beginning to understand the role of estrogens and androgens in not only the initiation, but the prognosis of patients with bladder cancer. And I think we will learn, as we know somewhat already, that estrogen clearly plays a role. Estrogen receptors play a role, androgens, testosterone play a role. There's an enzyme called aromatase, which converts testosterone to estrogen.

SCHERR

10:17:53
Also -- excuse me -- it converts estrogen to testosterone -- also plays a role. We know that tamoxifen, which is a medication many people are familiar with in the breast cancer world, may indeed have some role in controlling bladder cancer. So we're really learning about a lot of things in terms of hormonal manipulation of this disease.

REHM

10:18:12
Dr. Douglas Scherr of New York Presbyterian Hospital. Here in the studio, Dr. Neal Freedman of the National Cancer Institute. And Lawrence Rzepka, he is executive director of the Bladder Cancer Advocacy Network. Do join us, 800-433-8850. A difficult problem to say the least, but one we need to look at more carefully. Stay with us.

REHM

10:20:03
And welcome back. In this hour, we're talking about new studies from the National Cancer Institute, indicating a link -- not quite absolute -- between smoking and bladder cancer, but showing an increased risk for bladder cancer among women. While it used to be considered a disease of old men, clearly, women are now right up there and having their own problems with bladder cancer, especially in the diagnosis and, indeed, in the prognosis.

REHM

10:20:53
There is some question in my mind, Dr. Scherr, as to whether, considering this email, there may be some inherited quality. Here's Elise, who joins us on Facebook. She says, "Bladder cancer has killed every female of my mother's side, on up to my great grandmother, except for my mom, who died of inflammatory breast cancer when she was 32. I am 29. Every year, I get more and more concerned.

REHM

10:21:35
"Doctors will not let me get a mammogram, citing that I'm not even 30." Can you talk about inheritance factors, Dr. Scherr?

SCHERR

10:21:49
Sure. You know, unlike some other diseases -- for example, breast cancer, prostate cancer, colorectal cancers, where we have, clearly, delineated familial patterns of inheritance -- bladder cancer is a disease where we have not yet identified a strict familial inheritance of this cancer. Although there can be some familial clusterings (sp?) of the disease, there hasn't been yet one gene identified that puts a patient at risk for bladder cancer.

SCHERR

10:22:17
Now perhaps -- and, again, this goes into areas that we're not well-educated about. But perhaps there could be something, a tumor suppressor gene that somehow becomes inactivated by tobacco or other carcinogens that runs in families, and that perhaps puts those family members at greater risk of developing a disease, particularly if they're exposed to some of the potential carcinogens, in particular tobacco smoke.

SCHERR

10:22:41
But, again, we have not yet identified a strict familial or genetic pattern of this disease.

REHM

10:22:47
Larry Rzepka, bladder cancer is apparently the fifth most common cancer. It doesn't receive nearly as much attention as breast cancer. Why is that?

RZEPKA

10:23:04
Well, we're as stunned about it as you are, Diane. As you said, it's the fifth most common cancer. Yet when you look at the allocated research funds by the National Cancer Institute, and, among cancers, bladder cancer receives about the 24th amount of money allocated to do bladder cancer research. Now, we surely don't begrudge any of the other cancers, the funding they're getting. But it is quite common, and people still don't talk about it.

RZEPKA

10:23:36
And it's quite a surprise, probably because it's one of those below-the-waist type of diseases that people don't like to discuss sometimes. But it's become more and more important, that the public be aware of all the signs and it becomes an open discussion. It can no longer be behind closed doors.

REHM

10:24:01
Well -- and here's another message posted on Facebook by Sandra. She says, "My husband was diagnosed with bladder cancer. His surgeon said it was 100 percent caused by his years of smoking cigarettes. He knew about lung and heart problems, but bladder cancer? Who knew?" Dr. Freedman?

FREEDMAN

10:24:32
In our study, we found that half of bladder cancer could be attributed to smoking in men and half in women. And, for men, this has been seen before. But for studies in women, they were performed in populations where women who smoked a lot less than men. But in our study and in the U.S. population now, men and women smoke similar amounts.

FREEDMAN

10:24:52
And so, because of that, we think that's why smoking now explains a similar proportion of bladder cancer in both men and women.

REHM

10:25:00
Are young people beginning to smoke earlier in life than they used to, Dr. Freedman?

FREEDMAN

10:25:11
I can't answer that. I'm not sure. But I do know that the rates of smoking in young people are much higher than we would wish. We wish that no young child -- no young person is smoking.

REHM

10:25:23
Of course.

FREEDMAN

10:25:24
But the rates of smoking in young people now are just as high as they were five or 10 years ago.

REHM

10:25:30
Interesting. Dr. -- go ahead, Larry.

RZEPKA

10:25:34
Well, I'd like to add, you know, bladder cancer is really the quintessential poster child for the environment. For the environmental problems we have, as much as smoking has been a cause for 50 percent of it, as studies are showing, it could also be the general occupation some people have out there. I mean, there are chemicals and contagions that can affect the system and help cause bladder cancer.

RZEPKA

10:26:01
And, just for an example, even among men -- I mean, manufacturing workers, leather workers, painters, hairdressers, truck drivers, et cetera -- they are all exposed to certain chemicals and contagions out there that might be, or could be, and attribute -- can contribute to a diagnosis of bladder cancer.

RZEPKA

10:26:22
One of the studies, that was done several years ago, mentioned that our veterans and our current young men and women who are serving -- veterans are two times more likely to be diagnosed with bladder cancer than someone who has not served. Now, of course, they probably have smoked more. We understand that happens in the military. But on the naval yards and Army posts and Air Force bases, they are also exposed to many other chemicals.

REHM

10:26:53
Exactly. Dr. Scherr, as you know, five of America's six largest tobacco manufacturers sued the FDA to block the new requirement that graphic warnings cover half of every package sold by October 2012. Right here in front of me, I have three packages: two of Marlboro cigarettes and one of Romeo cigars. And these were actually purchased in Egypt.

REHM

10:27:37
On the front of each of these cigarettes is a fetus, and that fetus is clearly being damaged. On the front of the cigar package is a man with a ventilator mask over his face. And, clearly, in Arabic, there are written warnings. I'd be interested in your thoughts about more graphic warnings on cigarette packages, Dr. Scherr.

SCHERR

10:28:17
Well, it's a very interesting topic. I think, putting my medical hat aside, I feel, you know, looking at some of the advertising we see, some of the TV commercials, particularly here in New York that I've seen of people suffering from emphysema and lung damages, and I see in my own children, who view these commercials, I think, clearly, are turned off to the effects of tobacco and I don't think ever would consider starting smoking.

SCHERR

10:28:42
So I think prevention is absolutely critical in this disease, not only for bladder cancer, for all smoking-related illnesses. So I think these can be very, very effective. And, you know, obviously, you can see where the tobacco companies are coming from 'cause they want to sell cigarettes.

REHM

10:28:55
Sure.

SCHERR

10:28:56
I think these are effective. And I think what else needs to be evaluated -- and I think Dr. Freedman touched upon this in his paper -- is the composition of these cigarettes as well. I think we're seeing different cigarettes now than we saw 30, 40 years ago. And perhaps these can be more toxic, more damaging in terms of their ability to cause disease than what we've seen in the past. So I think the advertising platform is incredibly effective and should continue.

SCHERR

10:29:22
But I do think we should also begin to look at the composition of tobacco that we're seeing today as well.

REHM

10:29:27
When you talk about the composition of tobacco, there have been some who've said that additives have been placed in the cigarettes to help make them less unhealthy. Could those additives themselves be at fault, Dr. Scherr?

SCHERR

10:29:51
Well, again, I don't know the answer to that, but I think they certainly can be. And I think it's something that needs to be evaluated. And although -- and again, Dr. Freedman points this out in his paper. Although we begin to cut back on tar and nicotine, we've seen an increase in concentrations of other carcinogens, in particular the beta-naphthylamine, which is a known carcinogen, and other types of nitrosamines which can cause bladder cancer as well.

SCHERR

10:30:17
So one of the very interesting aspects is, you know, we, as the medical community, tend to evaluate smoking by something called pack years, where we talk about the number of packs a day a patient has smoked multiplied by the number of years. And I think what that does not capture is the intensity of tobacco exposure as well.

SCHERR

10:30:35
So, for example, someone who smokes a pack a day for 15 years, is that really the same as someone who smokes three packs a day for five years? So they're both considered a 15-pack-year history. But, in fact, my feeling is the intensity of tobacco exposure is probably more important than the total exposure itself.

REHM

10:30:55
I have to tell you, I have to admit that I smoked two packs a day from the age of 15 to 25. At that point, my husband said to me, I cannot bear the smell of smoke in your hair, on your clothing. I had smoked through my son's pregnancy -- my pregnancy with my son and my daughter. They're both extraordinarily healthy. That was 50 years ago. It seems to me that the content of tobacco has changed.

REHM

10:31:44
The content of elements in the environment has changed. Doesn't that make a difference, Dr. Freedman?

FREEDMAN

10:31:54
I think it does. More research is needed, as Dr. Scherr mentioned, about the constituents of tobacco smoke, the constituents of cigarettes. But, you know, there's been lots of changes. In addition to the addition of the filter, there -- and the decreasing concentrations of tar, there's been many other changes, in terms of the type of tobacco that's used, how the tobacco is prepared, and even the inhalation practices that people use.

FREEDMAN

10:32:20
There's a growing evidence that, with the addition of the filter, people are smoking more deeply and getting more smoke into them from the same cigarette. And all of this may contribute towards the increasing risk that we see with bladder cancer.

REHM

10:32:34
Dr. Neal Freedman, he is co-author of a report, a scientific investigator at the National Cancer Institute, looking at the correlation between smoking and bladder cancer. And you're listening to "The Diane Rehm Show." Here's a tweet from Ryan, who says, "Is there a notable difference in the chemical composition of a smoker's urine versus a non-smoker's?" Dr. Freedman.

FREEDMAN

10:33:11
Yes, there is. There's a number of biochemical markers of smoking that you can measure in the urine and then also in the blood. You -- unfortunately, we can't use this to figure out which are the carcinogens that might be affecting the bladder because when you smoke, you're exposed to all of the different compounds in the cigarettes. But there are clearer things that you can measure in the blood and urine.

REHM

10:33:31
Can you add to that, Dr. Scherr?

SCHERR

10:33:36
Well, yes. I (sounds like) wouldn't entirely agree with that. And, in fact, we've been working on a home testing kit. You know, one of the most exciting aspects, I think, that's happening in bladder cancer right now is something called biomarker discovery.

SCHERR

10:33:49
And what that is is evaluating things in the urine and in the blood or serum of patients to be able to do a real-time analysis of the presence or absence of certain "risk-factor molecules" that may sort of raise an eyebrow or indicate the presence of a bladder cancer.

SCHERR

10:34:06
So we're in the process of working with some of our engineers at Cornell University in Ithaca, where we're attempting to create a panel of approximately 25 biomarkers that, just with a single drop of urine, can be immediately detected and screen high-risk populations to determine whether or not they have some evidence of early bladder cancer.

REHM

10:34:27
Dr. Scherr, give us a sense of the signs of bladder cancer.

SCHERR

10:34:35
Well, I think, as was alluded to earlier in the conversation, the most common finding in someone with bladder cancer is having microscopic or gross evidence of blood in the urine, and that is the first sign. In its more advanced stages with large tumors, we sometimes see the presence of back pain. And that could be one of the reasons the tumor could be obstructing the kidneys, and it can present almost as if you're having a kidney stone.

SCHERR

10:35:02
And that could be one of the later signs of disease as it's progressed further. But microscopic or gross blood in the urine is, by far, the most common presentation of someone with bladder cancer. Occasionally, we also see what we call irritative urinary symptoms. Patients may complain of frequency, urgency, burning when they urinate, and these are some, also, early signs of the presence of bladder tumors.

SCHERR

10:35:25
Having said that, these are also the general signs and symptoms of particularly men who develop what we call lower urinary tract symptoms, which are consistent with an enlarged prostate.

REHM

10:35:38
So the prostate enlargement in men could somehow indicate that something is going wrong. But for women, you're saying it's only, perhaps, microscopic drops of blood in the urine?

SCHERR

10:36:01
Right. And I think that's, in part, what creates a bit of a delay for presentation of women, in that mostly their symptoms are not obviously attributable to an enlarged prostate as women do not have a prostate. And I think many, many more men are in tune with urologists. I think the vast majority of men at some point in their life have visited with a urologist, mainly for urinary symptoms as they get older.

SCHERR

10:36:24
Whereas women, obviously, you're not clearly going to see a urologist for prostatic symptoms. But I think the message needs to get out that any microscopic or, certainly, gross blood in the urine, although certainly can be from a urinary tract infection, I think bladder cancer needs to enter into the equation in the diagnostic algorithm.

REHM

10:36:43
Do you want to add to that, Dr. Freedman?

FREEDMAN

10:36:47
No. I think that's great.

REHM

10:36:48
Okay. And Larry, any comment?

RZEPKA

10:36:52
No, not at this time.

REHM

10:36:54
So the signs of bladder cancer that should absolutely initially take women and men to check out bladder cancer, the blood in the urine, but also for men, obstruction?

RZEPKA

10:37:16
Correct.

REHM

10:37:16
And also for men, perhaps even for women as well, a slower stream. All right. We've given you the outlines. Now, we invite your questions, comments. We'll take just a short break. We'll be right back.

REHM

10:40:03
And welcome back. We have an email regarding breast -- bladder cancer on -- from Karen, who says, "My husband has not smoked for 40 years. He's in between chemotherapy for metastatic muscle-invasive stage III bladder cancer. The efforts to make yet another cancer a lifestyle choice is very disheartening.

REHM

10:40:33
"There is the implication that cancer is something you bring on yourself, which is so unfair, especially as statistics show 40 percent of adults will develop cancer in their lifetime." Larry.

RZEPKA

10:40:52
Well, it alludes to what we talked about earlier today, that it is more than just smoking. But smoking is, right now, the major cause of bladder cancer. And, please, stop if you have started, or don't even start. But in saying that, it's the environment over the last 40, 50 years, carcinogens in the -- some of our drinking water, et cetera, that can be a cause. So people should not feel that they are responsible for it at all.

RZEPKA

10:41:19
What they should feel is that they should take responsibility now to go talk to their doctor, and if -- know the signs of what bladder cancer is.

REHM

10:41:29
All right. Let's go to Caroline in San Antonio, Texas. Good morning to you.

CAROLINE

10:41:36
Good morning. I had an experience with bladder cancer. Last year, I developed a UTI infection, urinary tract infection, and it did not heal. I took everything. I couldn't take some of the antibiotics. Anyway, this went on and on, and at the -- after about three-and-a-half, four months, I was sent to a urologist. He did a cystoscopy and discovered that I had a tumor. And he immediately said it is from cancer -- I mean, from smoking.

CAROLINE

10:42:13
And I was just shocked. I had no idea that I've had anything like that, but I was so frustrated with the UTI that it didn't respond to antibiotics. And it was a blessing because I never had a single sign of anything wrong with my bladder.

REHM

10:42:31
Interesting. Now, Caroline, what kind of treatment did you receive?

CAROLINE

10:42:37
He did -- almost immediately, he removed it surgically, and there were...

REHM

10:42:43
He removed what?

CAROLINE

10:42:44
The tumor...

REHM

10:42:45
Okay.

CAROLINE

10:42:45
...in my cancer...

REHM

10:42:46
Okay.

CAROLINE

10:42:47
...I mean, in my bladder. And then, also, I had a few little red spots, which are sort of precancerous apparently, and he treated those by laser. And that was the end of it. And I went back for -- I've been back for regular checkups, and I have no more sign of anything, thanks be to God. But I also have a male friend, and I'm -- I was 81 at the time that I developed this, or that I found it.

CAROLINE

10:43:17
And I have a male friend who happens to be homosexual, and he also has been -- has had bladder cancer. His was discovered when he actually saw blood in his urine. And for many years, he's been treated every three months. He goes in. They check, and every so often, he has to have BCG, I believe it is, injections of BCG fluid into his -- it's like a chemo for the bladder.

REHM

10:43:47
Interesting. Caroline, I'm so relieved for you. Dr. Scherr, how unusual is it that at her age she would have had this kind of cancer?

SCHERR

10:44:07
I would say it's not unusual at all. And, in fact, that's probably the most common presentation that we see in women who've had recurrent and recalcitrant urinary tract infections that are not successfully treated with antibiotics. And I think anyone with recurrent urinary tract infections should be evaluated cystoscopically to evaluate the internal part of the bladder.

SCHERR

10:44:29
And I think, fortunately, in this woman's case, this was a superficial tumor. And, in fact, 70 percent of all bladder cancers we diagnose, fortunately, fall into the superficial category and could be managed, just like her tumor was managed, with what we call a transurethral resection of a bladder tumor, which is an outpatient procedure, that we scrape the inner lining of the bladder, including the tumor out.

SCHERR

10:44:53
And we get adequate staging, in that we need to biopsy several layers of the bladder to insure that the tumor has not transgressed the wall of the bladder. And the two features that we really look at, from both the prognostic and the therapeutic standpoint, are what we call the stage and the grade. Stage is a reference to how deeply into the bladder wall it goes, and grade is a reference to the biologic aggressiveness of the cells themselves.

REHM

10:45:21
All right.

SCHERR

10:45:22
I would say this is a very common presentation.

REHM

10:45:24
Caroline, thanks for calling. I'm so glad that you're now well. Let's go to Hollis (sp?) in Morrisville, N.C. Good morning to you.

HOLLIS

10:45:38
Well, I'm 49 years old and a non-smoker. My father died in his 50s from bladder cancer. And a couple of years ago, my aunt has -- was diagnosed with bladder cancer and is doing fine. My question is -- I get frequent urinary tract infections, and they're resolved with medications. But, I guess, is there any sort of test that I should be doing once a year since I do have this history of bladder cancer?

REHM

10:46:12
Let me ask, did your mother and -- sorry -- your father and aunt smoke?

HOLLIS

10:46:20
No, they did not.

REHM

10:46:21
Okay.

HOLLIS

10:46:21
They did come from a family, though. My grandparents were very heavily smokers.

REHM

10:46:27
And, of course, that brings up the question of secondhand smoke, Dr. Freedman, but, also, are there tests she can take?

FREEDMAN

10:46:39
We should check with Dr. Scherr, but I'm not aware of screening tests for bladder cancer at this time. Development of early detection tests for cancers, of course, really important, but for many cancers, such tests don't exist.

REHM

10:46:52
Dr. Scherr.

SCHERR

10:46:54
Well, there's -- there are a few tests that can be done. Certainly, an analysis of the urine would be indicated. And what we look for, obviously, is for evidence of microscopic blood in the urine when you're not having a urinary tract infection. And, two, there's a test called a urine cytology.

SCHERR

10:47:10
And a urine cytology is when a cytopathologist, someone who's specially trained in looking at the cells within the urine, can determine whether there are actual cancer cells present in the urine. And it can be a very effective and very specific test for bladder cancer.

SCHERR

10:47:26
And someone who's had frequent urinary tract infections, with a family history, it's probably not unreasonable to be evaluated by a urologist for these tests and, perhaps, even have a cystoscopic evaluation to evaluate the inside of your bladder.

REHM

10:47:43
I'm sure, Larry Rzepka, you'd be in favor of that kind of periodic testing.

RZEPKA

10:47:51
Oh, very much so. In fact, I would encourage and easily agree with what Dr. Scherr said, that if you have a concern like that after several times of being treated for a urinary tract infection, you have some history in your family, please, talk to your doctor and ask, can they recommend a urologist or who would they suggest you see? So you can, one, bring up the conversation which is important, and two, have him know what your concerns are, or she.

REHM

10:48:20
Absolutely. To Nancy in Mountain City, Tenn., you're on the air.

NANCY

10:48:28
Good morning, Diane. Thank you for taking my call.

REHM

10:48:31
Of course.

NANCY

10:48:31
My husband died four years ago of bladder cancer.

REHM

10:48:35
Sorry.

NANCY

10:48:35
And he was one of those who did never, ever smoke. He was a veteran of 30 years in the Army and served in Vietnam. And his doctors at Duke University, when he was early diagnosed, said he had the most aggressive type of bladder cancer. And he had documentation of being exposed not only to Agent Orange in Vietnam, but more importantly to something they called Agent Blue, which was basically arsenic.

NANCY

10:49:04
And it was used heavy in Cambodia, which, of course, politically, at the time, we didn't admit being in Cambodia. But more and more veterans are showing up with this aggressive type of bladder cancer who were, in fact, exposed to chemicals in Vietnam. And I'm wondering -- we're talking about maybe 40 years ago. I'm wondering if your experts there have any comment about the distance, the length of time it took for this cancer to develop.

REHM

10:49:38
Larry.

RZEPKA

10:49:39
Well, I really can't address the issue of length of time. Though considering the way chemicals enter your bladder, they don't necessarily are all totally dissolved. So you could have been exposed to something many years ago, even smoking or other toxic chemicals, and still, 20 to 30 years later, have some repercussions from that.

RZEPKA

10:50:00
In regards to the Agent Orange and Agent Blue, the only thing I can say to you is, even today, the Veterans Administration has not recognized Agent Orange as a cause for bladder cancer. They have recognized it as a cause for other cancers, but not bladder cancer yet. And they have not recognized Agent Blue very well at all, mainly because of the political implications.

RZEPKA

10:50:24
So, right now, I can concur. And I've heard your story many times from other veterans. But there's no legal evidence at this time that could say that Agent Orange caused it. That's the best I can tell you.

REHM

10:50:43
Dr. Scherr.

SCHERR

10:50:45
Well, I guess, first off, I'm sorry to hear about your husband.

REHM

10:50:47
I should say.

SCHERR

10:50:49
I think that, you know, there's a lot to this process we just simply don't understand. We do realize and understand that there's a latency period. And the exposure to the carcinogen can, as mentioned, be 30 to 40 years later for the presentation of the bladder cancer. Now, whether your husband's bladder cancer is related to some of these military chemicals that he may have been exposed to, I think, we'll never know the answer to that.

SCHERR

10:51:15
I think the other issue, you know, back then, clearly, there were tons of people smoking. And although he was not a smoker himself, I'm sure he was exposed to a lot of other smokers around him. So it's a very, very different -- I should say, very, very difficult thing to sort of work out in terms of isolating which carcinogen was the culprit here, and I don't think we'll ever understand that.

SCHERR

10:51:36
The other issue is, you know, although 95 percent of bladder cancers are what we call transitional cell cancers, which are these classic smoking-related cancers, there are less common forms of bladder cancers called adenocarcinomas and squamous cell carcinomas. Squamous cell carcinoma, in particular, is very common in areas in the Middle East where a schistosomiasis is endemic in the water.

SCHERR

10:52:02
And so there are other types of bladder cancers that can be very, very aggressive that may indeed not be, per se, carcinogenic related. So it's a very complex picture.

REHM

10:52:13
All right. Let's go now to Suffolk, Va. Good morning, Cynthia.

CYNTHIA

10:52:19
Good morning, Diane. I'm a 69 -- well, I was 69 last year when I was diagnosed with bladder cancer, and it started the same way, with the repeated UTIs. And then I ended up having a cystoscopy in which the doctor said it looked -- he had two tiny tumors. And so I had those removed, and then the biopsy -- they decided to do the biological immune treatment for six weeks.

CYNTHIA

10:52:59
And then I had another biopsy. And the pathologist said there's something wrong with this, and said I have something that only 8 percent of patients get. And it was starting to attack the muscle wall. So I'm 70 years old, and I have lost my bladder. I had a major cystoscopy, you know, a hysterectomy, a -- an ileal conduit. And, you know, it all started with this UTI thing.

REHM

10:53:30
Oh, Cynthia, I'm so sorry for what you've gone through. But I'm glad the doctors did get to it. Now, Dr. Scherr, that sounds like an extreme, when the bladder cancer has begun to invade the muscular walls and all of that kind of surgery has to take place. How frequently does that happen?

SCHERR

10:53:59
Well, fortunately, that's not the most common presentation for bladder cancer, although we do see that. The vast majority of tumors, as I mentioned, are superficial. But in a significant percentage of patients, we do see invasive bladder cancer where it does invade into the muscle or beyond. And that does require more definitive surgical means.

SCHERR

10:54:18
In particular, as the listener just described, it requires removal of the bladder, called a radical cystectomy, and, in women, that also includes removal of the uterus and the ovaries. And so this, obviously, can be a life-altering event. I think we're fortunate now that we've sort of been able to improve upon the surgery. Oftentimes, this can be done laparoscopically or robotically.

SCHERR

10:54:38
But it's a major life-altering event, and it can be curative in a significant subset of patients. So, you know, I think in patients like this, where we see it begin to invade the muscle, this really needs to be addressed seriously and, oftentimes, requires multiple forms of therapy, surgery being one, potentially combined with chemotherapy as well.

REHM

10:54:58
And, final question for you, Dr. Scherr, you talked earlier about a scientist you're working with at Cornell University to develop an at-home screen test for bladder cancer. How far along are you? How soon do you think it might be available to the public generally?

SCHERR

10:55:22
Well, I think we're in the early stages of this, but these things tend to happen very quickly. And I think this, ultimately -- it would never be cost-effective, really, to screen the entire population. But I think this really would be focused for the "at-risk individuals," in that those patients who've had some environmental exposures, in particular, tobacco smoke, firefighters who also have exposure to smoke, these would be the focus of this test.

SCHERR

10:55:44
And I would say we're probably about two years away from having a product that can be utilized.

REHM

10:55:50
So what you just said puts me in mind of the question about secondhand smoke. Is that going to be as potentially lethal as smoking cigarettes?

SCHERR

10:56:05
Well, I think that remains to be seen. I think secondhand smoke can be a big problem. And, certainly, there are carcinogens in secondhand smoke that, if inhaled by bystanders, can have some of the same effects. I think, clearly, the intensity of the exposure is not as great as the firsthand smoker, but I think secondhand smoke can be problematic, without question.

REHM

10:56:26
Especially for very young people, I would think, Dr. Freedman.

FREEDMAN

10:56:30
Yes, I agree, though -- exactly -- though the intensity of the smoke from secondhand smoke is not as intense as if you're smoking the cigarette yourself. You're still exposed to all of the same carcinogens, and many of the carcinogens are known carcinogens for the bladder.

REHM

10:56:45
Dr. Neal Freedman of the National Cancer Institute, Dr. Douglas Scherr of New York Presbyterian Hospital and Lawrence Rzepka. He's with the Bladder Cancer Advocacy Network. Thank you all so much.

RZEPKA

10:57:05
Thank you.

SCHERR

10:57:05
Thank you very much.

REHM

10:57:06
And thanks for listening. I'm Diane Rehm.

ANNOUNCER

10:57:11
"The Diane Rehm Show" is produced by Sandra Pinkard, Nancy Robertson, Susan Nabors, Denise Couture, Monique Nazareth, Sarah Ashworth, Lisa Dunn and Nikki Jecks. The engineer is Tobey Schreiner. A.C. Valdez answers the phones. Visit drshow.org for audio archives, transcripts, podcasts and CD sales. Call 202-885-1200 for more information.
Transcripts of WAMU programs are available for personal use. Transcripts are provided "As Is" without warranties of any kind, either express or implied. WAMU does not warrant that the transcript is error-free. For all WAMU programs, the broadcast audio should be considered the authoritative version. Transcripts are owned by WAMU 88.5 FM American University Radio and are protected by laws in both the United States and international law. You may not sell or modify transcripts or reproduce, display, distribute, or otherwise use the transcript, in whole or in part, in any way for any public or commercial purpose without the express written permission of WAMU. All requests for uses beyond personal and noncommercial use should be referred to (202) 885-1200.

Our address has changed!

The Diane Rehm Show is produced by member-supported WAMU 88.5 in Washington DC.